COMPLETED

Impact of Time Restricted Feeding on Daily Protein Requirements

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The investigators aim to assess 24-hour protein kinetics at two different levels of protein intake: 0.8 (RDA) and 1.6g/kg/day (2RDA) during a normal dietary (TRAD) and a time restricted feeding (TRF) pattern in older adults.

Official Title

Impact of Time Restricted Feeding on Daily Protein Requirements

Quick Facts

Study Start:2023-03-29
Study Completion:2024-10-03
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT05610644

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:50 Years to 75 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Men and women ages 50-75 years.
  2. 2. BMI 20-30 kg/m2 inclusive.
  3. 3. Capable of providing informed consent.
  4. 4. COVID-19 negative and/or asymptomatic
  1. 1. Subject who does not/will not eat animal protein sources.
  2. 2. Body mass index \<20 or \>30.
  3. 3. Hemoglobin \<10g/dL at screening.
  4. 4. Platelets \<150,000/uL at screening.
  5. 5. History of diabetes.
  6. 6. History of chemotherapy or radiation therapy for cancer in the 6 months prior to enrollment.
  7. 7. History of gastrointestinal bypass/reduction surgery.
  8. 8. History of a chronic inflammatory disease (e.g. what?)
  9. 9. Currently receiving androgen (e.g., testosterone) or anabolic (e.g., GH, IGF-I) therapy.
  10. 10. Currently using prescription blood thinning medications.
  11. 11. Currently using corticosteroid medications.
  12. 12. Unable or unwilling to suspend aspirin use for 7 days prior to Visit 3.
  13. 13. Unwilling to avoid using protein or amino-acid supplements during participation.
  14. 14. Subjects who are unwilling to fast overnight.
  15. 15. Participating in \>200 minutes/week of vigorous exercise and/or \>4 days/week of resistance training.

Contacts and Locations

Principal Investigator

David Church
PRINCIPAL_INVESTIGATOR
UAMS (University of Arkansas for Medical Sciences)

Study Locations (Sites)

University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205
United States

Collaborators and Investigators

Sponsor: University of Arkansas

  • David Church, PRINCIPAL_INVESTIGATOR, UAMS (University of Arkansas for Medical Sciences)

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-03-29
Study Completion Date2024-10-03

Study Record Updates

Study Start Date2023-03-29
Study Completion Date2024-10-03

Terms related to this study

Additional Relevant MeSH Terms

  • Nutrition Disorders in Old Age